Home Insulin Delivery (Dosing) Devices Market Insights, Global Outlook and Forecast 2022-2028
Home Insulin Delivery (Dosing) Devices Market Insights, Global Outlook and Forecast 2022-2028
The Global Home Insulin Delivery (Dosing) Devices Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Tandem Diabetes Care, Biocon, Roche Holding AG, Insulet Corporation, B. Braun, BD, Eli Lilly and Company, Novo Nordisk, Sanofi, Wockhardt, Ypsomed Holding, Medtronic, Julphar, Beta Bionics, Copernicus, Dance Biopharm, Debiotech, MannKind, Owen Mumford, SOOIL, Valeritas, West Pharma
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of Home Insulin Delivery (Dosing) Devices in global, including the following market information:
Global Home Insulin Delivery (Dosing) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Home Insulin Delivery (Dosing) Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Home Insulin Delivery (Dosing) Devices companies in 2021 (%)
The global Home Insulin Delivery (Dosing) Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Home Insulin Delivery (Dosing) Devices include Tandem Diabetes Care, Biocon, Roche Holding AG, Insulet Corporation, B. Braun, BD, Eli Lilly and Company, Novo Nordisk and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Home Insulin Delivery (Dosing) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Home Insulin Delivery (Dosing) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Type, 2021 (%)
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Global Home Insulin Delivery (Dosing) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
Global Home Insulin Delivery (Dosing) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Home Insulin Delivery (Dosing) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Home Insulin Delivery (Dosing) Devices revenues share in global market, 2021 (%)
Key companies Home Insulin Delivery (Dosing) Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Home Insulin Delivery (Dosing) Devices sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Tandem Diabetes Care
Biocon
Roche Holding AG
Insulet Corporation
B. Braun
BD
Eli Lilly and Company
Novo Nordisk
Sanofi
Wockhardt
Ypsomed Holding
Medtronic
Julphar
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
MannKind
Owen Mumford
SOOIL
Valeritas
West Pharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Home Insulin Delivery (Dosing) Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Home Insulin Delivery (Dosing) Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Home Insulin Delivery (Dosing) Devices Overall Market Size
2.1 Global Home Insulin Delivery (Dosing) Devices Market Size: 2021 VS 2028
2.2 Global Home Insulin Delivery (Dosing) Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Home Insulin Delivery (Dosing) Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Home Insulin Delivery (Dosing) Devices Players in Global Market
3.2 Top Global Home Insulin Delivery (Dosing) Devices Companies Ranked by Revenue
3.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Companies
3.4 Global Home Insulin Delivery (Dosing) Devices Sales by Companies
3.5 Global Home Insulin Delivery (Dosing) Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Home Insulin Delivery (Dosing) Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Home Insulin Delivery (Dosing) Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Home Insulin Delivery (Dosing) Devices Players in Global Market
3.8.1 List of Global Tier 1 Home Insulin Delivery (Dosing) Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Home Insulin Delivery (Dosing) Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Home Insulin Delivery (Dosing) Devices Market Size Markets, 2021 & 2028
4.1.2 Insulin Pens
4.1.3 Insulin Pumps
4.1.4 Insulin Syringes
4.1.5 Others
4.2 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue & Forecasts
4.2.1 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2022
4.2.2 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue, 2023-2028
4.2.3 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Home Insulin Delivery (Dosing) Devices Sales & Forecasts
4.3.1 By Type - Global Home Insulin Delivery (Dosing) Devices Sales, 2017-2022
4.3.2 By Type - Global Home Insulin Delivery (Dosing) Devices Sales, 2023-2028
4.3.3 By Type - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
4.4 By Type - Global Home Insulin Delivery (Dosing) Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Home Insulin Delivery (Dosing) Devices Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue & Forecasts
5.2.1 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2022
5.2.2 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue, 2023-2028
5.2.3 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Home Insulin Delivery (Dosing) Devices Sales & Forecasts
5.3.1 By Application - Global Home Insulin Delivery (Dosing) Devices Sales, 2017-2022
5.3.2 By Application - Global Home Insulin Delivery (Dosing) Devices Sales, 2023-2028
5.3.3 By Application - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
5.4 By Application - Global Home Insulin Delivery (Dosing) Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Home Insulin Delivery (Dosing) Devices Market Size, 2021 & 2028
6.2 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue & Forecasts
6.2.1 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2022
6.2.2 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue, 2023-2028
6.2.3 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Home Insulin Delivery (Dosing) Devices Sales & Forecasts
6.3.1 By Region - Global Home Insulin Delivery (Dosing) Devices Sales, 2017-2022
6.3.2 By Region - Global Home Insulin Delivery (Dosing) Devices Sales, 2023-2028
6.3.3 By Region - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028
6.4.2 By Country - North America Home Insulin Delivery (Dosing) Devices Sales, 2017-2028
6.4.3 US Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.4.4 Canada Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.4.5 Mexico Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028
6.5.2 By Country - Europe Home Insulin Delivery (Dosing) Devices Sales, 2017-2028
6.5.3 Germany Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5.4 France Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5.5 U.K. Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5.6 Italy Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5.7 Russia Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5.8 Nordic Countries Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.5.9 Benelux Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028
6.6.2 By Region - Asia Home Insulin Delivery (Dosing) Devices Sales, 2017-2028
6.6.3 China Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.6.4 Japan Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.6.5 South Korea Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.6.6 Southeast Asia Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.6.7 India Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028
6.7.2 By Country - South America Home Insulin Delivery (Dosing) Devices Sales, 2017-2028
6.7.3 Brazil Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.7.4 Argentina Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales, 2017-2028
6.8.3 Turkey Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.8.4 Israel Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
6.8.6 UAE Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Tandem Diabetes Care
7.1.1 Tandem Diabetes Care Corporate Summary
7.1.2 Tandem Diabetes Care Business Overview
7.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.1.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.1.5 Tandem Diabetes Care Key News
7.2 Biocon
7.2.1 Biocon Corporate Summary
7.2.2 Biocon Business Overview
7.2.3 Biocon Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.2.4 Biocon Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.2.5 Biocon Key News
7.3 Roche Holding AG
7.3.1 Roche Holding AG Corporate Summary
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.3.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.3.5 Roche Holding AG Key News
7.4 Insulet Corporation
7.4.1 Insulet Corporation Corporate Summary
7.4.2 Insulet Corporation Business Overview
7.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.4.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.4.5 Insulet Corporation Key News
7.5 B. Braun
7.5.1 B. Braun Corporate Summary
7.5.2 B. Braun Business Overview
7.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.5.4 B. Braun Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.5.5 B. Braun Key News
7.6 BD
7.6.1 BD Corporate Summary
7.6.2 BD Business Overview
7.6.3 BD Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.6.4 BD Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.6.5 BD Key News
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Corporate Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.7.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly and Company Key News
7.8 Novo Nordisk
7.8.1 Novo Nordisk Corporate Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.8.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.8.5 Novo Nordisk Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.9.4 Sanofi Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Key News
7.10 Wockhardt
7.10.1 Wockhardt Corporate Summary
7.10.2 Wockhardt Business Overview
7.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.10.4 Wockhardt Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.10.5 Wockhardt Key News
7.11 Ypsomed Holding
7.11.1 Ypsomed Holding Corporate Summary
7.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Business Overview
7.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.11.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.11.5 Ypsomed Holding Key News
7.12 Medtronic
7.12.1 Medtronic Corporate Summary
7.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Business Overview
7.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.12.4 Medtronic Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.12.5 Medtronic Key News
7.13 Julphar
7.13.1 Julphar Corporate Summary
7.13.2 Julphar Home Insulin Delivery (Dosing) Devices Business Overview
7.13.3 Julphar Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.13.4 Julphar Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.13.5 Julphar Key News
7.14 Beta Bionics
7.14.1 Beta Bionics Corporate Summary
7.14.2 Beta Bionics Business Overview
7.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.14.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.14.5 Beta Bionics Key News
7.15 Copernicus
7.15.1 Copernicus Corporate Summary
7.15.2 Copernicus Business Overview
7.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.15.4 Copernicus Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.15.5 Copernicus Key News
7.16 Dance Biopharm
7.16.1 Dance Biopharm Corporate Summary
7.16.2 Dance Biopharm Business Overview
7.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.16.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.16.5 Dance Biopharm Key News
7.17 Debiotech
7.17.1 Debiotech Corporate Summary
7.17.2 Debiotech Business Overview
7.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.17.4 Debiotech Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.17.5 Debiotech Key News
7.18 MannKind
7.18.1 MannKind Corporate Summary
7.18.2 MannKind Business Overview
7.18.3 MannKind Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.18.4 MannKind Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.18.5 MannKind Key News
7.19 Owen Mumford
7.19.1 Owen Mumford Corporate Summary
7.19.2 Owen Mumford Business Overview
7.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.19.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.19.5 Owen Mumford Key News
7.20 SOOIL
7.20.1 SOOIL Corporate Summary
7.20.2 SOOIL Business Overview
7.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.20.4 SOOIL Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.20.5 SOOIL Key News
7.21 Valeritas
7.21.1 Valeritas Corporate Summary
7.21.2 Valeritas Business Overview
7.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.21.4 Valeritas Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.21.5 Valeritas Key News
7.22 West Pharma
7.22.1 West Pharma Corporate Summary
7.22.2 West Pharma Business Overview
7.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Major Product Offerings
7.22.4 West Pharma Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)
7.22.5 West Pharma Key News
8 Global Home Insulin Delivery (Dosing) Devices Production Capacity, Analysis
8.1 Global Home Insulin Delivery (Dosing) Devices Production Capacity, 2017-2028
8.2 Home Insulin Delivery (Dosing) Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Home Insulin Delivery (Dosing) Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Home Insulin Delivery (Dosing) Devices Supply Chain Analysis
10.1 Home Insulin Delivery (Dosing) Devices Industry Value Chain
10.2 Home Insulin Delivery (Dosing) Devices Upstream Market
10.3 Home Insulin Delivery (Dosing) Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Home Insulin Delivery (Dosing) Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Home Insulin Delivery (Dosing) Devices in Global Market
Table 2. Top Home Insulin Delivery (Dosing) Devices Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Home Insulin Delivery (Dosing) Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Companies, 2017-2022
Table 5. Global Home Insulin Delivery (Dosing) Devices Sales by Companies, (K Units), 2017-2022
Table 6. Global Home Insulin Delivery (Dosing) Devices Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Home Insulin Delivery (Dosing) Devices Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Home Insulin Delivery (Dosing) Devices Product Type
Table 9. List of Global Tier 1 Home Insulin Delivery (Dosing) Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Home Insulin Delivery (Dosing) Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2017-2022
Table 15. By Type - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2023-2028
Table 16. By Application – Global Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2017-2022
Table 20. By Application - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2023-2028
Table 21. By Region – Global Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2017-2022
Table 25. By Region - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2023-2028
Table 26. By Country - North America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022
Table 29. By Country - North America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028
Table 30. By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022
Table 33. By Country - Europe Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028
Table 34. By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022
Table 37. By Region - Asia Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028
Table 38. By Country - South America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022
Table 41. By Country - South America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028
Table 46. Tandem Diabetes Care Corporate Summary
Table 47. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offerings
Table 48. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Biocon Corporate Summary
Table 50. Biocon Home Insulin Delivery (Dosing) Devices Product Offerings
Table 51. Biocon Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Roche Holding AG Corporate Summary
Table 53. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offerings
Table 54. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Insulet Corporation Corporate Summary
Table 56. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offerings
Table 57. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. B. Braun Corporate Summary
Table 59. B. Braun Home Insulin Delivery (Dosing) Devices Product Offerings
Table 60. B. Braun Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. BD Corporate Summary
Table 62. BD Home Insulin Delivery (Dosing) Devices Product Offerings
Table 63. BD Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Eli Lilly and Company Corporate Summary
Table 65. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offerings
Table 66. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Novo Nordisk Corporate Summary
Table 68. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offerings
Table 69. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Sanofi Corporate Summary
Table 71. Sanofi Home Insulin Delivery (Dosing) Devices Product Offerings
Table 72. Sanofi Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Wockhardt Corporate Summary
Table 74. Wockhardt Home Insulin Delivery (Dosing) Devices Product Offerings
Table 75. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Ypsomed Holding Corporate Summary
Table 77. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offerings
Table 78. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Medtronic Corporate Summary
Table 80. Medtronic Home Insulin Delivery (Dosing) Devices Product Offerings
Table 81. Medtronic Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Julphar Corporate Summary
Table 83. Julphar Home Insulin Delivery (Dosing) Devices Product Offerings
Table 84. Julphar Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Beta Bionics Corporate Summary
Table 86. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offerings
Table 87. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Copernicus Corporate Summary
Table 89. Copernicus Home Insulin Delivery (Dosing) Devices Product Offerings
Table 90. Copernicus Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Dance Biopharm Corporate Summary
Table 92. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offerings
Table 93. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Debiotech Corporate Summary
Table 95. Debiotech Home Insulin Delivery (Dosing) Devices Product Offerings
Table 96. Debiotech Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. MannKind Corporate Summary
Table 98. MannKind Home Insulin Delivery (Dosing) Devices Product Offerings
Table 99. MannKind Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Owen Mumford Corporate Summary
Table 101. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offerings
Table 102. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. SOOIL Corporate Summary
Table 104. SOOIL Home Insulin Delivery (Dosing) Devices Product Offerings
Table 105. SOOIL Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Valeritas Corporate Summary
Table 107. Valeritas Home Insulin Delivery (Dosing) Devices Product Offerings
Table 108. Valeritas Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. West Pharma Corporate Summary
Table 110. West Pharma Home Insulin Delivery (Dosing) Devices Product Offerings
Table 111. West Pharma Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Home Insulin Delivery (Dosing) Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 113. Global Home Insulin Delivery (Dosing) Devices Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Home Insulin Delivery (Dosing) Devices Production by Region, 2017-2022 (K Units)
Table 115. Global Home Insulin Delivery (Dosing) Devices Production by Region, 2023-2028 (K Units)
Table 116. Home Insulin Delivery (Dosing) Devices Market Opportunities & Trends in Global Market
Table 117. Home Insulin Delivery (Dosing) Devices Market Drivers in Global Market
Table 118. Home Insulin Delivery (Dosing) Devices Market Restraints in Global Market
Table 119. Home Insulin Delivery (Dosing) Devices Raw Materials
Table 120. Home Insulin Delivery (Dosing) Devices Raw Materials Suppliers in Global Market
Table 121. Typical Home Insulin Delivery (Dosing) Devices Downstream
Table 122. Home Insulin Delivery (Dosing) Devices Downstream Clients in Global Market
Table 123. Home Insulin Delivery (Dosing) Devices Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Home Insulin Delivery (Dosing) Devices Segment by Type
Figure 2. Home Insulin Delivery (Dosing) Devices Segment by Application
Figure 3. Global Home Insulin Delivery (Dosing) Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Home Insulin Delivery (Dosing) Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. Home Insulin Delivery (Dosing) Devices Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Home Insulin Delivery (Dosing) Devices Revenue in 2021
Figure 9. By Type - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 10. By Type - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 11. By Type - Global Home Insulin Delivery (Dosing) Devices Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 13. By Application - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 14. By Application - Global Home Insulin Delivery (Dosing) Devices Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 16. By Region - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 17. By Country - North America Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 18. By Country - North America Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 19. US Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 24. Germany Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 25. France Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 33. China Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 37. India Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 39. By Country - South America Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 40. Brazil Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028
Figure 44. Turkey Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Home Insulin Delivery (Dosing) Devices
Research Methodology:
Home Insulin Delivery (Dosing) Devices Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|